Newamsterdam Pharma Stock Overlap Studies Double Exponential Moving Average
| NAMSW Stock | 9.53 0.62 6.11% |
| Symbol |
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Double Exponential Moving Average indicator was developed by Patrick Mulloy. It consists of a single exponential moving average and a double exponential moving average. This indicator is more responsive to NewAmsterdam Pharma changes than the simple moving average.
NewAmsterdam Pharma Technical Analysis Modules
Most technical analysis of NewAmsterdam Pharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for NewAmsterdam from various momentum indicators to cycle indicators. When you analyze NewAmsterdam charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About NewAmsterdam Pharma Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NewAmsterdam Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of NewAmsterdam Pharma based on widely used predictive technical indicators. In general, we focus on analyzing NewAmsterdam Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NewAmsterdam Pharma's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of NewAmsterdam Pharma's intrinsic value. In addition to deriving basic predictive indicators for NewAmsterdam Pharma, we also check how macroeconomic factors affect NewAmsterdam Pharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2023 | 2024 (projected) | Graham Number | 13.04 | 10.2 | Receivables Turnover | 41.7 | 37.06 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NewAmsterdam Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NewAmsterdam Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NewAmsterdam Pharma's short interest history, or implied volatility extrapolated from NewAmsterdam Pharma options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Gambling Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | Warren Buffett Holdings Invested over 60 shares | |
 | Hedge Favorites Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | Macroaxis Picks Invested over 40 shares | |
 | Driverless Cars Invested few shares | |
 | Investor Favorites Invested few shares | |
 | Automobiles and Trucks Invested over 50 shares | |
 | Manufacturing Invested over 30 shares | |
 | FinTech Invested over 60 shares | |
 | Artificial Intelligence Invested few shares |
Additional Tools for NewAmsterdam Stock Analysis
When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.